Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-07-23
1995-06-20
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514253, 514258, A61K 31505
Patent
active
054261074
ABSTRACT:
Compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof are selective cGMP PDE inhibitors which are useful in the treatment of such diseases and adverse conditions as angina, hypertension, congestive heart failure, reduced blood vessel patency, peripheral vascular disease, stroke, bronchitis, chronic asthma, allergic asthma, allergic rhinitis, glaucoma, and diseases characterized by disorders of gut motility.
REFERENCES:
patent: 3036070 (1962-05-01), Druey et al.
patent: 3600689 (1971-08-01), Druey et al.
patent: 4052390 (1977-10-01), Broughton
patent: 4167568 (1979-09-01), Knowles et al.
patent: 4666908 (1987-05-01), Hamilton
patent: 5075310 (1991-12-01), Coates
patent: 5250534 (1993-10-01), Bell et al.
patent: 5346901 (1994-09-01), Bell et al.
Hamilton, Journal of Medicinal Chemistry, 30, 1987, 91-96.
Tokyo Koho, Chem. Abs. vol. 106, Entry 101967h, Abstracting Japan 61-236778 (1987).
Bell Andrew S.
Terrett Nicholas K.
Benson Gregg C.
Daus Donald G.
Pfizer Inc.
Richardson Peter C.
Ronau Robert T.
LandOfFree
Pyrazolopyrimidinone antianginal agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolopyrimidinone antianginal agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolopyrimidinone antianginal agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1844278